The DES Center

Filter Your Results

 

News

 

Abbott Vascular Presents ABSORB Trial Data

September 22, 2010—Abbott Vascular (Santa Clara, CA) announced that the results from the first 45 patients enrolled in the second stage of the ABSORB trial were presented by…

Boston Scientific’s Promus Element Stent Receives CE Mark for Diabetic and AMI Patients

September 21, 2010—Boston Scientific Corporation (Natick, MA) announced that its Promus Element everolimus-eluting coronary stent system has received CE Mark approval for us…

Nine-Month PLATINUM QCA Data Presented for Boston Scientific’s Promus Element

September 21, 2010—Boston Scientific Corporation (Natick, MA) announced that data from its PLATINUM QCA study were presented by Principal Investigator Ian T. Meredith, MD, a…

Medtronic Launches Resolute Integrity DES in Europe

August 30, 2010 — Medtronic, Inc. (Minneapolis, MN) announced the receipt of CE mark approval for the Resolute Integrity drug-eluting stent (DES) system for the treatment of…

Ten-Year Follow-Up Results Presented for the Cordis Cypher SES

August 31, 2010—At the European Society of Cardiology meeting in Stockholm, Cordis Corporation (Bridgewater, NJ) announced the results of 10-year follow-up tests on the firs…

Biotronik Begins BIOSOLVE Study of Its Drug-Eluting Absorbable Metal Stent

August 13, 2010—Biotronik AG (Bülach, Switzerland) announced that its DREAMS (Drug-Eluting Absorbable Metal Scaffold) device has been successfully implanted in the first pa…

Israeli Study Shows That DES Improve Long-Term PCI Outcomes

August 17, 2010—The Society for Cardiovascular Angiography and Interventions (SCAI) announced that investigators at the Rabin Medical Center in Israel have determined that t…

Boston Scientific Begins Enrollment for Trial of Bioabsorbable Synergy DES

August 3, 2010—Boston Scientific Corporation (Natick, MA) announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and …

 

advertisement

Top 5 Top 5 In DES Center

The Impact of Thin-Strut, Biodegradable Polymer Stent Designs

How these stent design characteristics may affect PCI outcomes going forward.

By Raffaele Piccolo, MD; and Thomas Pilgrim, MD

Biosensors’ LEADERS FREE II BioFreedom Pivotal Study Begins Enrollment

Reva Medical's Fantom Bioresorbable Coronary Scaffold Approved in Europe

Biotronik's Magmaris Resorbable Scaffold Shows Reduced Risk of Thrombosis

Medtronic Launches Resolute Onyx Drug-Eluting Stent in United States

 

Centers

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

Other Resources

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.